[Federal Register Volume 84, Number 221 (Friday, November 15, 2019)] [Notices] [Pages 62534-62537] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2019-24805] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2016-N-2544] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Devices; Current Good Manufacturing Practice Quality System Regulation AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (PRA). DATES: Fax written comments on the collection of information by December 16, 2019. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, Fax: 202-395-7285, or emailed to [email protected]. All comments should be identified with the OMB control number 0910-0073. Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-8867, [email protected]. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Medical Devices: Current Good Manufacturing Practice Quality System Regulation--21 CFR Part 820 OMB Control Number 0910-0073--Extension Under section 520(f) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 360j(f)), the Secretary of the Department of Health and Human Services has the authority to prescribe regulations requiring that the methods used in, and the facilities and controls used for, the manufacture, preproduction design validation (including a process to assess the performance of a device, but not including an evaluation of the safety and effectiveness of a device), packing, storage, and installation of a device conform to current good manufacturing practice (CGMP), as described in such regulations, to assure that the device will be safe and effective and otherwise in compliance with the FD&C Act. The CGMP quality system (QS) regulation implementing authority provided by this statutory provision is found under part 820 (21 CFR part 820) and sets forth basic CGMP requirements governing the design, manufacture, packing, labeling, storage, installation, and servicing of all finished medical devices intended for human use. The authority for this regulation is covered under sections 501, 502, 510, 513, 514, 515, 518, 519, 520, 522, 701, 704, 801, and 803 of the FD&C Act (21 U.S.C. 351, 352, 360, 360c, 360d, 360e, 360h, 360i, 360j, 360l, 371, 374, 381, and 383). The CGMP/QS regulation includes requirements for purchasing and service controls, clarifies recordkeeping requirements for device failure and complaint investigations, clarifies requirements for verifying/validating production processes and process or product changes, and clarifies requirements for product acceptance activities, quality data evaluations, and corrections of nonconforming product/ quality problems. Requirements are compatible with specifications in the international standards ``ISO 9001: Quality Systems Model for Quality Assurance in Design/Development, Production, Installation, and Servicing.'' The CGMP/QS information collections will assist FDA inspections of manufacturers for compliance with QS requirements encompassing design, production, installation, and servicing processes. [[Page 62535]] Section 820.20(a) through (e) requires management with executive responsibility to establish, maintain, and/or review the following topics: (1) The quality policy, (2) the organizational structure, (3) the quality plan, and (4) the quality system procedures of the organization. Section 820.22 requires the conduct and documentation of QS audits and reaudits. Section 820.25(b) requires the establishment of procedures to identify training needs and documentation of such training. Section 820.30(a)(1) and (b) through (j) requires, in respective order, the establishment, maintenance, and/or documentation of the following topics: (1) Procedures to control design of class III and class II devices and certain class I devices as listed therein; (2) plans for design and development activities and updates; (3) procedures identifying, documenting, and approving design input requirements; (4) procedures defining design output, including acceptance criteria, and documentation of approved records; (5) procedures for formal review of design results and documentation of results in the design history file (DHF); (6) procedures for verifying device design and documentation of results and approvals in the DHF; (7) procedures for validating device design, including documentation of results in the DHF; (8) procedures for translating device design into production specifications; (9) procedures for documenting, verifying, and validating approved design changes before implementation of changes; and (10) the records and references constituting the DHF for each type of device. Section 820.40 requires manufacturers to establish and maintain procedures controlling approval and distribution of required documents and document changes. Section 820.40(a) and (b) requires the establishment and maintenance of procedures for the review, approval, issuance, and documentation of required records (documents) and changes to those records. Section 820.50(a) and (b) requires the establishment and maintenance of procedures and requirements to ensure service and product quality, records of acceptable suppliers, and purchasing data describing specified requirements for products and services. Sections 820.60 and 820.65 require, respectively, the establishment and maintenance of procedures for identifying all products from receipt to distribution and for using control numbers to track surgical implants and life-sustaining or supporting devices and their components. Section 820.70(a) through (e), (g)(1) through (3), (h), and (i) requires the establishment, maintenance, and/or documentation of the following topics: (1) Process control procedures; (2) procedures for verifying or validating changes to specification, method, process, or procedure; (3) procedures to control environmental conditions and inspection result records; (4) requirements for personnel hygiene; (5) procedures for preventing contamination of equipment and products; (6) equipment adjustment, cleaning, and maintenance schedules; (7) equipment inspection records; (8) equipment tolerance postings, procedures for utilizing manufacturing materials expected to have an adverse effect on product quality; and (9) validation protocols and validation records for computer software and software changes. Sections 820.72(a), (b)(1) and (2), and 820.75(a) through (c) require, respectively, the establishment, maintenance, and/or documentation of the following topics: (1) Equipment calibration and inspection procedures; (2) national, international, or in-house calibration standards; (3) records that identify calibrated equipment and next calibration dates; (4) validation procedures and validation results for processes not verifiable by inspections and tests; (5) procedures for keeping validated processes within specified limits; (6) records for monitoring and controlling validated processes; and (7) records of the results of revalidation where necessitated by process changes or deviations. Sections 820.80(a) through (e) and 820.86, respectively, require the establishment, maintenance, and/or documentation of the following topics: (1) Procedures for incoming acceptance by inspection, test, or other verification; (2) procedures for ensuring that in-process products meet specified requirements and the control of product until inspection and tests are completed; (3) procedures for, and records that show, incoming acceptance or rejection is conducted by inspections, tests, or other verifications; (4) procedures for, and records that show, finished devices meet acceptance criteria and are not distributed until device master record (DMR) activities are completed; (5) records in the device history record (DHR) showing acceptance dates, results, and equipment used; and (6) the acceptance/ rejection identification of products from receipt to installation and servicing. Sections 820.90(a), (b)(1) and (2), and 820.100 require, respectively, the establishment, maintenance and/or documentation of the following topics: (1) Procedures for identifying, recording, evaluating, and disposing of nonconforming product; (2) procedures for reviewing and recording concessions made for, and disposition of, nonconforming product; (3) procedures for reworking products, evaluating possible adverse rework effect and recording results in the DHR; (4) procedures and requirements for corrective and preventive actions, including analysis, investigation, identification and review of data, records, causes, and results; and (5) records for all corrective and preventive action activities. Section 820.100(a)(1) through (7) states that procedures and requirements shall be established and maintained for corrective/ preventive actions, including the following: (1) Analysis of data from process, work, quality, servicing records, investigation of nonconformance causes; (2) identification of corrections and their effectiveness; (3) recording of changes made; and (4) appropriate distribution and managerial review of corrective and preventive action information. Section 820.120 states that manufacturers shall establish/ maintain procedures to control labeling storage/application, examination/release for storage and use, and to document those procedures. Sections 820.120(b) and (d), 820.130, 820.140, 820.150(a) and (b), 820.160(a) and (b), and 820.170(a) and (b), respectively, require the establishment, maintenance, and/or documentation of the following topics: (1) Procedures for controlling and recording the storage, examination, release, and use of labeling; (2) the filing of labels/ labeling used in the DHR; (3) procedures for controlling product storage areas and receipt/dispatch authorizations; (4) procedures controlling the release of products for distribution; (5) distribution records that identify consignee, product, date, and control numbers; and (6) instructions, inspection and test procedures that are made available, and the recording of results for devices requiring installation. Sections 820.180(b) and (c), 820.181(a) through (e), 820.184(a) through (f), and 820.186 require, respectively, the maintenance of records that are: (1) Retained at prescribed site(s), made readily available and accessible to FDA, and retained for the device's life expectancy or for 2 years; (2) contained or referenced in a DMR consisting of device, process, quality assurance, packaging and labeling, and [[Page 62536]] installation, maintenance, and servicing specifications and procedures; (3) contained in a DHR and demonstrate the manufacture of each unit, lot, or batch of product in conformance with DMR and regulatory requirements include manufacturing and distribution dates, quantities, acceptance documents, labels and labeling, and control numbers; and (4) contained in a quality system record, consisting of references, documents, procedures, and activities not specific to particular devices. Sections 820.198(a) through (g) and 820.200(a) through (d), respectively, require the establishment, maintenance, and/or documentation of the following topics: (1) Complaint files and procedures for receiving, reviewing, and evaluating complaints; (2) complaint investigation records identifying the device, complainant, and relationship of the device to the incident; (3) complaint records that are reasonably accessible to the manufacturing site or at prescribed sites; (4) procedures for performing and verifying that device servicing requirements are met and that service reports involving complaints are processed as complaints; and (5) service reports that record the device, service activity, and test and inspection data. Section 820.250 requires the establishment and maintenance of procedures to identify valid statistical techniques necessary to verify process and product acceptability; and sampling plans, when used, which are written and based on valid statistical rationale; and procedures for ensuring adequate sampling methods. The CGMP/QS regulation added design and purchasing controls, modified previous critical device requirements, revised previous validation and other requirements, and harmonized device CGMP requirements with QS specifications in the international standard ``ISO 9001: Quality Systems Model for Quality Assurance in Design/ Development, Production, Installation, and Servicing.'' The rule does not apply to manufacturers of components or parts of finished devices, or to manufacturers of human blood and blood components subject to 21 CFR part 606. With respect to devices classified in class I, design control requirements apply only to class I devices listed in Sec. 820.30(a)(2) of the regulation. The rule imposes burden upon: (1) Finished device manufacturer firms, which are subject to all recordkeeping requirements; (2) finished device contract manufacturers, specification developers; and (3) re-packer, re-labelers, and contract sterilizer firms, which are subject only to requirements applicable to their activities. In addition, remanufacturers of hospital single-use devices are now considered to have the same requirements as manufacturers in regard to the regulation. The establishment, maintenance, and/or documentation of procedures, records, and data required by the regulation assists FDA in determining whether firms are in compliance with CGMP requirements, which are intended to ensure that devices meet their design, production, labeling, installation, and servicing specifications and, thus are safe, effective, and suitable for their intended purpose. In particular, compliance with CGMP design control requirements should decrease the number of design-related device failures that have resulted in deaths and serious injuries. The CGMP/QS regulation applies to approximately 27,074 respondents. This estimate is based on a query of the Agency's registration and listing database. Respondents to this information collection have no reporting activities, but must make required records available for review or copying during FDA inspection. Except for manufacturers, not every type of firm is subject to every CGMP/QS requirement. For example, all are subject to Quality Policy (Sec. 820.20(a)), Document Control (Sec. 820.40), and other requirements, whereas only manufacturers and specification developers are subject to subpart C, Design Controls. The PRA burden placed on the 27,074 establishments is an average burden. In the Federal Register of July 31, 2019 (84 FR 37317), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received. FDA estimates the burden of this collection of information as follows: Table 1--Estimated Annual Recordkeeping Burden \1\ ---------------------------------------------------------------------------------------------------------------- Number of Average burden Activity/21 CFR section Number of records per Total annual per Total hours recordkeepers recordkeeper records recordkeeping ---------------------------------------------------------------------------------------------------------------- Quality policy-820.20(a)........ 27,074 1 27,074 7 189,518 Organization-820.20(b).......... 27,074 1 27,074 4 108,296 Management review-820.20(c)..... 27,074 1 27,074 6 162,444 Quality planning-820.20(d)...... 27,074 1 27,074 10 270,740 Quality system procedures- 27,074 1 27,074 10 270,740 820.20(e)...................... Quality audit-820.22............ 27,074 1 27,074 33 893,442 Training-820.25(b).............. 27,074 1 27,074 13 351,962 Design procedures-820.30(a)(1).. 27,074 1 27,074 2 54,148 Design and development planning- 27,074 1 27,074 6 162,444 820.30(b)...................... Design input-820.30(c).......... 27,074 1 27,074 2 54,148 Design output-820.30(d)......... 27,074 1 27,074 2 54,148 Design review-820.30(e)......... 27,074 1 27,074 23 622,702 Design verification-820.30(f)... 27,074 1 27,074 37 1,001,738 Design validation-820.30(g)..... 27,074 1 27,074 37 1,001,738 Design transfer-820.30(h)....... 27,074 1 27,074 3 81,222 Design changes-820.30(i)........ 27,074 1 27,074 17 460,258 Design history file-820.30(j)... 27,074 1 27,074 3 81,222 Document controls-820.40........ 27,074 1 27,074 9 243,666 Documentation approval and 27,074 1 27,074 2 54,148 distribution and document changes-820.40(a) and (b)...... Purchasing controls-820.50(a)... 27,074 1 27,074 22 595,628 Purchasing data-820.50(b)....... 27,074 1 27,074 6 162,444 Identification-820.60........... 27,074 1 27,074 1 27,074 Traceability-820.65............. 27,074 1 27,074 1 27,074 Production and process controls- 27,074 1 27,074 2 54,148 820.70(a)...................... [[Page 62537]] Production and process changes 27,074 1 27,074 2 54,148 and environmental control- 820.70(b) and (c).............. Personnel-820.70(d)............. 27,074 1 27,074 3 81,222 Contamination control-820.70(e). 27,074 1 27,074 2 54,148 Equipment maintenance schedule, 27,074 1 27,074 1 27,074 inspection, and adjustment- 820.70(g)(1)-(3)............... Manufacturing material-820.70(h) 27,074 1 27,074 2 54,148 Automated processes-820.70(i)... 27,074 1 27,074 8 216,592 Control of inspection, 27,074 1 27,074 5 135,370 measuring, and test equipment- 820.72(a)...................... Calibration procedures, 27,074 1 27,074 1 27,074 standards, and records- 820.72(b)(1)-(2)............... Process validation-820.75(a).... 27,074 1 27,074 3 81,222 Validated process parameters, 27,074 1 27,074 1 27,074 monitoring, control methods, and data-820.75(b)............. Revalidation-820.75(c).......... 27,074 1 27,074 1 27,074 Acceptance activities-820.80(a)- 27,074 1 27,074 5 135,370 (e)............................ Acceptance status-820.86........ 27,074 1 27,074 1 27,074 Control of nonconforming product- 27,074 1 27,074 5 135,370 820.90(a)...................... Nonconforming product review/ 27,074 1 27,074 5 135,370 disposition procedures and rework procedures-820.90(b)(1)- (2)............................ Procedures for corrective/ 27,074 1 27,074 12 324,888 preventive actions- 820.100(a)(1)-(7).............. Corrective/preventive activities- 27,074 1 27,074 1 27,074 820.100(b)..................... Labeling procedures-820.120(b).. 27,074 1 27,074 1 27,074 Labeling documentation- 27,074 1 27,074 1 27,074 820.120(d)..................... Device packaging-820.130........ 27,074 1 27,074 1 27,074 Handling-820.140................ 27,074 1 27,074 6 162,444 Storage-820.150(a) and (b)...... 27,074 1 27,074 6 162,444 Distribution procedures and 27,074 1 27,074 1 27,074 records-820.160(a) and (b)..... Installation-820.170............ 27,074 1 27,074 2 54,148 Record retention period- 27,074 1 27,074 2 54,148 820.180(b) and (c)............. Device master record-820.181.... 27,074 1 27,074 1 27,074 Device history record-820.184... 27,074 1 27,074 1 27,074 Quality system record-820.186... 27,074 1 27,074 1 27,074 Complaint files-820.198(a)-(g).. 27,074 1 27,074 5 135,370 Servicing procedures and reports- 27,074 1 27,074 3 81,222 820.200(a) and (d)............. Statistical techniques 27,074 1 27,074 1 27,074 procedures and sampling plans- 820.250........................ ------------------------------------------------------------------------------- Total....................... .............. .............. .............. .............. 9,421,752 ---------------------------------------------------------------------------------------------------------------- \1\ There are no capital costs or operating and maintenance costs associated with this collection of information. Our estimated burden for the information collection reflects an overall increase of 812,928 hours. We attribute this adjustment to an increase in the number of respondents. Dated: November 6, 2019. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2019-24805 Filed 11-14-19; 8:45 am] BILLING CODE 4164-01-P